[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-363837-105":59,"doc-detail-363837-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","surfaceome-reprogramming-of-stemsomes-promotes-lung-cancer-targeting-via-potentiated-receptorligand-interactions","Surfaceome Reprogramming of Stemsomes Promotes Lung Cancer Targeting via Potentiated Receptor–Ligand Interactions","","Non-small-cell lung cancer remains lethal because mutation-specific therapies only benefit small patient subsets and drug resistance arises inevitably. This study presents a universal approach using mesenchymal stem cell-derived nanovesicles (stemsomes) reprogrammed with dexamethasone, a repurposed anti-inflammatory compound. Dexamethasone-primed stemsomes fused with liposomes show markedly enhanced tumor targeting and therapeutic effects. Transcriptomic and siRNA knockdown results indicate adhesion protein upregulation, including ephrin type-A receptor 2 and NOTCH3, supporting multivalent interaction networks mapped by computations and simulations.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/surfaceome-reprogramming-of-stemsomes-promotes-lung-cancer-targeting-via-potentiated-receptorligand-interactions/363837/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/surfaceome-reprogramming-of-stemsomes-promotes-lung-cancer-targeting-via-potentiated-receptorligand-interactions/363837.png","ImageObject",300,407,{"name":92,"@type":93},"Guten tag","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is lung cancer difficult to treat with current mutation-specific therapies?","Question",{"text":112,"@type":113},"Non-small-cell lung cancer has high mortality because therapies target only limited patient subsets based on specific mutations. Drug resistance and reduced long-term effectiveness further limit current options.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What strategy does the study propose to improve lung cancer targeting?",{"text":117,"@type":113},"The study reprograms mesenchymal stem cell-derived nanovesicles (stemsomes) by priming them with dexamethasone and fusing them with liposomes to enhance tumor targeting and therapeutic performance.",{"name":119,"@type":110,"acceptedAnswer":120},"What drives the improved tumor cell targeting according to the experiments?",{"text":121,"@type":113},"Transcriptomic profiling and siRNA-mediated knockdown indicate dexamethasone-induced upregulation of key cell adhesion proteins, specifically ephrin type-A receptor 2 and NOTCH3, enabling stronger multivalent interactions with NSCLC cells.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},363837,1790624130,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":19,"preview_urls":144},687212321768,"https://ap-avatar.wpscdn.com/avatar/a0010bdbe886d2fe77?x-image-process=image/resize,m_fixed,w_180,h_180&k=1789897067658708522","Advanced Science  \n| [www.advancedscience.com](www.advancedscience.com)\u003Cbr> RESEARCH ARTICLE \u003Cbr>Surfaceome Reprogramming of Stemsomes Promotes Lung Cancer Targeting via Potentiated Receptor–Ligand Interactions\u003Cbr>Geunhye Kim1  In Ah Kwon1, 2  Bo Seop Jeong1  Hyo Seon Kim3  Joo-Hwan Park4  Sung Jean Park5  Sang-Rae Lee6, 7   Youngki Lee8, 9  Dongwoo Khang1, 3, 9 \u003Cbr>1 Department of Health Sciences and Technology, GAIHST, Gachon University, Incheon, South Korea  2 Ectosome Inc., Incheon, South Korea  3 Department of Physiology, College of Medicine, Gachon University, Incheon, South Korea  4 Division of Medical Oncology, Department of Internal Medicine, Gachon University School of Medicine, Gil Medical Center, Incheon, South Korea  5 College of Pharmacy and Gachon Institute of Pharmaceutical Sciences, Gachon University, Incheon, South Korea  6 Department of Pharmacology, Ajou University School of Medicine, Suwon, South Korea  7 Efficacy Test Center For Mental & Behavioral Disorders, Ajou University Hospital, Suwon, South Korea  8 Department of Biopharmaceutical Sciences, Cheongju University, Cheongju, South Korea  9 Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon, South Korea\u003Cbr>Correspondence: Sang-Rae Lee ([lsr21@ajou.ac.kr](lsr21@ajou.ac.kr))  Youngki Lee (brew071@cju.ac.kr)  Dongwoo Khang (dkhang@gachon.ac.kr)\u003Cbr>Received: 19 February 2026  Revised: 23 May 2026  Accepted: 29 May 2026\u003Cbr>Keywords: cell membrane-derived vesicle | dexamethasone | liposome | lung cancer | mesenchymal stem cell\u003Cbr>\u003Cbr>ABSTRACT\u003Cbr>Non-small-cell lung cancer (NSCLC) mortality remains high because mutation-specific therapies target only small patient subsetsand inevitably encounter drug resistance. In this regard, multipathway-assisted mesenchymal stem cell-derived nanovesicles (stemsomes) offer a promising universal platform for overcoming the unmet needs of lung cancer therapeutics, particularly for patients lacking identifiable oncogenic drivers. This study introduces a novel strategy in which dexamethasone, a compound conventionally used as an anti-inflammatory drug, is repurposed to enhance the tumor-targeting capabilities of stemsomes. Nanoparticles engineered by fusing these dexamethasone-primed stemsomes with liposomes exhibit markedly improved therapeutic effects. According to transcriptomic and siRNA-mediated knockdown experiments, this enhanced targeting of tumor cells is driven by the dexamethasone-induced upregulation of key cell adhesion proteins, specifically ephrin type-A receptor 2 and neurogenic locus notch homolog protein 3. Furthermore, a comprehensive map of potential adhesion interactions and computational simulations suggest a multivalent interaction network between the surfaces of dexamethasone-primed stemsomesand NSCLC H1975 cells. These findings indicate the discovery of a highly translational and mutation-independent strategy that represents a promising novel mechanism for engineering vesicle surfaces for NSCLC therapy. |  |\n| --- | --- |\n| 1  Introduction\u003Cbr>Lung cancer remains the most lethal malignancy globally and is responsible for approximately 1.8 million deaths annually, with non-small-cell lung cancer (NSCLC) constituting over 85% of | cases [1] . The effective management of advanced-stage NSCLC is hindered by limited tumor specificity and considerable systemic toxicity associated with traditional chemotherapy [2–4] . While various targeted therapies were developed, their clinical application remains restricted to specific patient subsets. For instance, |\n| Geunhye Kim and In Ah Kwon contributed equally to this study. |  |\n| This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.\u003Cbr>© 2026 The Author(s). Advanced Science published by Wiley-VCH GmbH |  |\n\nAdvanced Science, 2026; 0:e76039 1 of 20  \n[https://doi.org/10.1002/advs.76039](https://doi.org/1","cbCaio2mSLn565gl","https://ap.wps.com/l/cbCaio2mSLn565gl","pdf",23643263,"English","# Abstract\n# Introduction","[{\"question\":\"Why is lung cancer difficult to treat with current mutation-specific therapies?\",\"answer\":\"Non-small-cell lung cancer has high mortality because therapies target only limited patient subsets based on specific mutations. Drug resistance and reduced long-term effectiveness further limit current options.\"},{\"question\":\"What strategy does the study propose to improve lung cancer targeting?\",\"answer\":\"The study reprograms mesenchymal stem cell-derived nanovesicles (stemsomes) by priming them with dexamethasone and fusing them with liposomes to enhance tumor targeting and therapeutic performance.\"},{\"question\":\"What drives the improved tumor cell targeting according to the experiments?\",\"answer\":\"Transcriptomic profiling and siRNA-mediated knockdown indicate dexamethasone-induced upregulation of key cell adhesion proteins, specifically ephrin type-A receptor 2 and NOTCH3, enabling stronger multivalent interactions with NSCLC cells.\"}]","Surfaceome Reprogramming of Stemsomes Promotes Lung Cancer Targeting via Potentiated Receptor–Ligand Interactions | PDF",1790153500,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b00dee337ca546acb93f61500d633ecc.webp",983,1283,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e45ecdec6a5811d5a00b454dd310e62f.webp",982,1281,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/319324926e0c545b0c1dddba4520bd24.webp",981,1280,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ff38d110112f19bf49da3d2b379f2528.webp",980,1279]